Long-Term Adverse Events of Rituximab in Multiple Sclerosis Patients, Isfahan, Iran

Long-Term Adverse Events of Rituximab in Multiple Sclerosis Patients, Isfahan, Iran

Background: This study’s objective was to assess the adverse events (AEs) of rituximab (RTX) therapy in people with multiple sclerosis (pwMS). Methods: This observational study was conducted on clinical data of pwMS who visited an MS center in Iran from January 2015 to January 2018 and underwent RTX...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Rahimisadegh, Omid Mirmosayyeb, Shakiba Houshi, Alireza Afshari-Safavi, Elham Moases Ghaffary, Fereshteh Ashtari, Vahid Shaygannejad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-06-01
Series:International Journal of Preventive Medicine
Subjects:
adverse drug reactions
ms
multiple sclerosis
rituximab
safety
Online Access:https://journals.lww.com/10.4103/ijpvm.ijpvm_366_22
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items